BROADFIN CAPITAL, LLC Information

300 PARK AVENUE, 25TH FLOOR, NEW YORK, New York, 10022, (212) 808-2463

Report Date: 12/31/2014

Position Statistics

Total Positions 79
New Positions 10
Increased Positions 37
Decreased Positions 25
Positions with Activity 62
Sold Out Positions 8
Total Mkt Value (in $ millions) 1,376

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 0.66%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial 1.35%
Healthcare 87.22%
Services 0%
Technology
Transportation
Utilities

10 New Positions as of 12/31/2014

Company Class Value of Shares ($1,000s) Change in Value ($1,000s) Change (%) ▲ Shares Held
ADMA BIOLOGICS INC COM 3,814 3,814 New 389,193
AMARIN CORP PLC SPONS ADR NEW 5,227 5,227 New 2,233,746
AUSPEX PHARMACEUTICALS INC COM 10,027 10,027 New 100,000
HEARTWARE INTL INC COM 4,389 4,389 New 50,000
LIGAND PHARMACEUTICALS INC COM NEW 15,345 15,345 New 199,000
MASIMO CORP COM 3,229 3,229 New 97,900
MEDGENICS INC COM NEW 8,262 8,262 New 1,025,000
PARATEK PHARMACEUTICALS INC COM 8,136 8,136 New 260,283
RAPTOR PHARMACEUTICAL CORP COM 169 169 New 15,558
SALIX PHARMACEUTICALS INC COM 17,281 17,281 New 100,000


Create your free portfolio